Phase II Early Behavioral Intervention in BMT w/ Sleep Disturbance-Assess QOL+Fatigue+Cognitive f(x)
Completed · Not applicable
Conditions studied: Cognition Disorders, Fatigue, Sleep Disorders, Other Complications of Bone Marrow Transplant
In brief
This pilot clinical trial studies early brief behavioral intervention in treating sleep disturbance and improving quality of life in patients undergoing bone marrow transplant (BMT). A brief behavioral intervention may reduce symptoms of insomnia and fatigue and improve quality of life and cognitive function in patients undergoing BMT
Key facts
- Study ID
- NCT01536977
- Run by
- Stanford University
- People needed
- 29
- Starts
- 2012-03-01
- Expected to finish
- 2013-09-01
- Last updated by the study team
- 2014-06-02
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient is scheduled to receive bone marrow transplantation.
- Patient has a diagnosis of Non-Hodgkin's Lymphoma
- Patient is at least 21 years old
- Patient is able to understand written and spoken English
- has preferred sleep phase between 9:00 pm and 3:00 am and a habitual rise time between 4:00 am and 11:00 am
- Patient receives a score of 8 or more on the Insomnia Severity Index or takes sleep medications 3 times a week
You may not qualify if…
- Has an unstable medical or psychiatric illness (Axis I - current or within the last 5 years)
- Existing cognitive disability
- Is currently pregnant or nursing
- Has a history of substance abuse or meets criteria for current alcohol abuse or dependence
- Has a self-reported history of chronic pre-existing insomnia, sleep apnea or RSL syndrome
Where it is running
- Stanford University — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.